These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6056057)

  • 1. Some 2,3,6,8-tetrasubstituted quinazolone hydrazides as monoamine oxidase inhibitors.
    Parmar SS; Arora RC
    J Med Chem; 1967 Nov; 10(6):1182-3. PubMed ID: 6056057
    [No Abstract]   [Full Text] [Related]  

  • 2. Substituted quinazolonephenoxyethylhydrazines as monoamine oxidase inhibitors.
    Parmar SS; Arora RC
    J Med Chem; 1970 Jan; 13(1):135-6. PubMed ID: 5412085
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis of some N-substituted eleostearic acid hydrazides as potential monoamine oxidase inhibitors.
    Hsu SY; Huang CL; Waters IW
    J Med Chem; 1973 May; 16(5):450-2. PubMed ID: 4146252
    [No Abstract]   [Full Text] [Related]  

  • 4. Guanylhydrazones, another class of monoamine oxidase inhibitors.
    Mutschler E; Springer J; Wassermann O
    Biochem Pharmacol; 1970 Jan; 19(1):9-15. PubMed ID: 5507652
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of rabbit liver mitochondrial monoamine oxidase by new hydrazine derviatives. I. Active moietes of the compounds 31037-S and 31087-S.
    Kurosawa A
    Chem Pharm Bull (Tokyo); 1969 Jan; 17(1):36-42. PubMed ID: 5771628
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combined inhibition of monoamine oxidase].
    Nikol'skaia EB; Iagodina OV; Khovanskikh AE
    Dokl Akad Nauk; 1999 Apr; 365(6):829-31. PubMed ID: 10368758
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between CNS depressant and enzyme inhibitory properties of substituted quinazolone 1,3,4-oxadiazoles.
    Barthwal JP; Tandon SK; Agarwal VK; Dixit KS; Parmar SS
    J Pharm Sci; 1973 Apr; 62(4):613-7. PubMed ID: 4698982
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of rabbit liver mitochondrial monoamine oxidase by new hydrazine derivatives. 3. Secondary action of the compounds 31037-S and 31087-S on the preincubated enzyme.
    Kurosawa A
    Chem Pharm Bull (Tokyo); 1969 Jan; 17(1):49-53. PubMed ID: 5771630
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of monoamine oxidation in rat liver mitochondria.
    Basu PS
    Biochem Pharmacol; 1975 Dec; 24(24):2269-71. PubMed ID: 1218099
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on monoamine oxidase (report XXIV). Effect of harmine on monoamine oxidase.
    Yasuhara H
    Jpn J Pharmacol; 1974 Aug; 24(4):523-33. PubMed ID: 4156374
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study in vitro and in vivo of the monoamine oxidase inhibitory properties of diacylhydrazines].
    Cuparencu B; Barzu T; Cojocaru Z
    J Physiol (Paris); 1969; 61 Suppl 1():112-3. PubMed ID: 5401989
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of rabbit liver mitochondrial monoamine oxidase by new hydrazine derivatives. II. Probable prosthetic groups of the enzyme, and their blocking by the compound 31037-S or 31087-S.
    Kurosawa A
    Chem Pharm Bull (Tokyo); 1969 Jan; 17(1):43-8. PubMed ID: 5771629
    [No Abstract]   [Full Text] [Related]  

  • 13. N-substituted cyclopropylamines as monoamine oxidase inhibitors. Structure-activity relationships. Dopa potentiation in mice and in vitro inhibition of kynuramine oxidation.
    Mills J; Kattau R; Slater IH; Fuller RW
    J Med Chem; 1968 Jan; 11(1):95-7. PubMed ID: 4384132
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure-activity relationships of monoamine oxidase inhibitors.
    Fujita T
    J Med Chem; 1973 Aug; 16(8):923-30. PubMed ID: 4745836
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple forms of monoamine oxidase. Comparison of in vitro and in vivo inhibition patterns.
    Collins GG; Youdim MB; Sandler M
    Biochem Pharmacol; 1972 Jul; 21(14):1995-8. PubMed ID: 4405452
    [No Abstract]   [Full Text] [Related]  

  • 16. [Derivatives of hydrazides and hydrazines inhibiting monoamine oxidase. Mechanisms cited to account for their pharmacological effects].
    LEVY J
    Actual Pharmacol (Paris); 1961; 14():125-73. PubMed ID: 14464772
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation between monoamine oxidase inhibitors and anticonvulsants.
    Dwivedi C; Misra RS; Chaudhari A; Parmar SS
    J Natl Med Assoc; 1980 Oct; 72(10):953-5. PubMed ID: 7420438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Styrlquinazolones as monoamine oxidase inhibitors.
    Misra RS; Chaudhari A; Chaturvedi AK; Parmar SS; Rama Sastry BV
    Pharmacol Res Commun; 1977 May; 9(5):437-46. PubMed ID: 882587
    [No Abstract]   [Full Text] [Related]  

  • 19. Monoamine oxidase inhibitors.
    Ho BT
    J Pharm Sci; 1972 Jun; 61(6):821-37. PubMed ID: 4558257
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hypotensive effect and anti-monoaminoxidase activity of fluoronitrocarbonic acid hydrazides].
    Beznosko BK; Bachurin SO; Brel' VK; Dodonov MV; Dubova LG
    Dokl Akad Nauk SSSR; 1989; 304(2):461-4. PubMed ID: 2499445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.